Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.
Clinical trial NCT06818565 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06818565
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2026-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.